Robert van Nostrand

Robert van Nostrand

Fortune : 438 886 $ au 31/08/2026

69 ans
Health Technology
Commercial Services
Process Industries

Profil

Robert L.
van Nostrand
is Independent Chairman at Yield10 Bioscience, Inc. since 2011.
Treasurer & Director at New York Biotechnology Association, Inc. Director at Brany LLC since 2011.
Director at ITI, Inc. (New York) since 2014.
Director at Sellas Life Sciences Group Ltd. since 2017.
Independent Director at SELLAS Life Sciences Group, Inc. since 2017.
Director at LikeMinds, Inc. (Massachusetts).
Member at Association of Biofinance Officers.
Formerly Chairman at Farmingdale College Foundation.
Independent Director at Achillion Pharmaceuticals, Inc. from 2007 to 2020.
Director at Achillion Pharmaceuticals, Inc. Director at Apex Bioventures Acquisition Corp.
from 2006 to 2009.
Independent Director at Enumeral Biomedical Holdings, Inc. from 2014 to 2018.
Director at Apex Bioventures LLC from 2006 to 2009.
Director at Enumeral Biomedical Corp.
Director at SELLAS Life Sciences Group, Inc. Lead Independent Director at Intra-Cellular Therapies, Inc. from 2014 to 2025.
Chief Compliance Officer & Senior Vice President at OSI Pharmaceuticals, Inc. from 2005 to 2007.
Chief Financial Officer & Executive Vice President at Applied Genetics, Inc. Dermatics from 2007 to 2008.
Chief Financial Officer & Executive Vice President at Aureon Biosciences, Inc. in 2010.
Manager at Touche Ross & Co. Chief Financial Officer & Executive Vice President at Aureon Laboratories, Inc. Education includes undergraduate degree from Long Island University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/04/2026 32 900 ( 0,02 % ) 438 886 $ 31/08/2026

Postes actifs de Robert van Nostrand

SociétésPosteDébut
YIELD10 BIOSCIENCE, INC. Président 08/11/2011
SELLAS LIFE SCIENCES GROUP, INC. Directeur/Membre du Conseil 29/12/2017
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 29/12/2017
ITI, Inc. (New York)
Directeur/Membre du Conseil 01/01/2014
Directeur/Membre du Conseil 01/01/2011
Association of Biofinance Officers
Corporate Officer/Principal -
Directeur/Membre du Conseil 20/07/2012

Anciens postes connus de Robert van Nostrand

SociétésPosteFin
INTRA-CELLULAR THERAPIES, INC. Directeur/Membre du Conseil 02/04/2025
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Robert van Nostrand

Formation de Robert van Nostrand

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées22

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Touche Ross & Co.

Commercial Services

Commercial Services

Association of Biofinance Officers

Apex Bioventures LLC

Commercial Services

Commercial Services

Health Technology

ITI, Inc. (New York)

Health Technology

Health Technology

Health Technology

Commercial Services

Aureon Laboratories, Inc.

  1. Bourse
  2. Insiders
  3. Robert van Nostrand
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇